TurnCare, Inc. Announces John F. Milligan, PhD, former CEO of Gilead Sciences, joins Board of Directors
PALO ALTO, Calif., Jan. 11, 2024 /PRNewswire/ — TurnCare, a leading medical technology and services company dedicated to advancing how hospitals manage high acuity patients, is proud to announce the addition of John F. Milligan, Ph.D., investor, innovator, and former CEO of Gilead, to its Board of Directors.
Related news for (PACB)
- MoBot alert highlights: NASDAQ: IMCC, NASDAQ: BIAF, NASDAQ: HOLO, NYSE: JOBY, NASDAQ: PACB (05/28/25 02:00 PM)
- Breaking News: MoBot’s Latest Update as of 04/09/25 09:00 AM
- Today’s Top Performers: MoBot’s Market Review 02/14/25 09:00 AM
- PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
- PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024